Skip to content
Clinical Trials – home

Gemeinschaftspraxis Dres. Holger Kittner und Kerstin Hartig

Research site

Germany Kurze Str. 7, 04683 Naunhof, Germany

  • 1 trial recruiting
  • Obesity · Irritable bowel syndrome · Arteriosclerosis
  • Adult patients

About Specializations

Gemeinschaftspraxis Dres. Holger Kittner und Kerstin Hartig in Naunhof, Germany specialises in clinical trials of conditions such as Obesity, Irritable bowel syndrome, Arteriosclerosis, Major depression, and other specialisations. This site conducts important research.

Main research areas of the site

Gastroenterology

The medical center is at the forefront of gastroenterology, focusing on innovative treatments for digestive disorders. The center's research is particularly concentrated on improving patient outcomes in conditions such as Irritable Bowel Syndrome (IBS).

  • Diarrhoea-predominant IBS
  • Microbiome-based therapies
  • Symptom management

By exploring the efficacy of novel treatments like Symbioflor®2, the center contributes significantly to the understanding and management of IBS, offering new hope for patients with this challenging condition.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Kurze Str. 704683 NaunhofGermany
Recruiting now
1 trial
Conditions studied
5

More sites in NaunhofGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

6 clinical trials

Study on the Effectiveness of E. coli DSM 17252 for Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:SymbioPharm GmbH

Arteriosclerosis

Not yet recruiting

Study of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.

Obesity

Not recruiting

Efficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:Metsera Inc.

Obesity

Not recruiting

A study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:Metsera Inc.

Major depression

Not recruiting

Study of lavender oil (Silexan) in patients with mild to moderate major depressive disorder comparing its effectiveness to placebo

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Lavender Oil
  • Sponsor:Dr. Willmar Schwabe GmbH & Co. KG

Diabetic neuropathy

Not recruiting

Study on Medical Cannabis Aerosol for Treating Diabetic Nerve Pain in Patients Using Syqe Inhaler

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cannabis Sativa Flower
  • Sponsor:Syqe Medical Ltd.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.